These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38773622)

  • 1. Facing the complex challenges of people with epidermolysis bullosa in Austria: a mixed methods study on burdens and helpful practices.
    Salamon G; Field-Werners U; Strobl S; Hübl V; Diem A
    Orphanet J Rare Dis; 2024 May; 19(1):211. PubMed ID: 38773622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
    Salamon G; Strobl S; Field-Werners U; Diem A; Schwieger-Briel A; Pope E
    Br J Dermatol; 2024 Jun; 191(1):75-81. PubMed ID: 38261404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermolysis bullosa care in Austria and the Epidermolysis Bullosa House Austria.
    Pohla-Gubo G; Hintner H
    Dermatol Clin; 2010 Apr; 28(2):415-20, xv. PubMed ID: 20447517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EB (epidermolysis bullosa)-House Austria: Pioneering work for the care of patients with rare diseases.
    Prodinger C; Laimer M; Bauer JW; Hintner H
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1229-1235. PubMed ID: 32776692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial impact of epidermolysis bullosa on patients: A qualitative study.
    Sangha N; MacLellan AN; Pope E
    Pediatr Dermatol; 2021 Jul; 38(4):819-824. PubMed ID: 34152033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosa.
    Prodinger C; Diem A; Ude-Schoder K; Piñón-Hofbauer J; Kitzmueller S; Bauer JW; Laimer M
    Orphanet J Rare Dis; 2020 Jul; 15(1):182. PubMed ID: 32650809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines.
    Martin K; Geuens S; Asche JK; Bodan R; Browne F; Downe A; García García N; Jaega G; Kennedy B; Mauritz PJ; Pérez F; Soon K; Zmazek V; Mayre-Chilton KM
    Orphanet J Rare Dis; 2019 Jun; 14(1):133. PubMed ID: 31186066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family burden of children suffering from epidermolysis bullosa.
    DE Stefano S; Grassi FS; Lalatta F; Scuvera G; Brena M; Grillo P; Peves Rios WE; Guez S
    Ital J Dermatol Venerol; 2021 Oct; 156(5):580-587. PubMed ID: 33034432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers.
    Bruckner AL; Losow M; Wisk J; Patel N; Reha A; Lagast H; Gault J; Gershkowitz J; Kopelan B; Hund M; Murrell DF
    Orphanet J Rare Dis; 2020 Jan; 15(1):1. PubMed ID: 31900176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.
    Krämer S; Lucas J; Gamboa F; Peñarrocha Diago M; Peñarrocha Oltra D; Guzmán-Letelier M; Paul S; Molina G; Sepúlveda L; Araya I; Soto R; Arriagada C; Lucky AW; Mellerio JE; Cornwall R; Alsayer F; Schilke R; Antal MA; Castrillón F; Paredes C; Serrano MC; Clark V
    Spec Care Dentist; 2020 Nov; 40 Suppl 1(Suppl 1):3-81. PubMed ID: 33202040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and clinical severity in people with epidermolysis bullosa - A proposal for assessing nutritional compromise by body mass index (Birmingham Epidermolysis Bullosa Severity Score).
    Togo CCG; Zidório APC; Sá NM; Dutra ES
    Nutr Hosp; 2024 Apr; 41(2):400-408. PubMed ID: 38149521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hindi translation and validation of quality of life score in Indian patients with epidermolysis bullosa; and its correlation with the clinical severity assessment scores: A cross-sectional study.
    Bishnoi A; Manjunath S; Kishore K; De D; Handa S; Murrell DF; Mahajan R
    Indian J Dermatol Venereol Leprol; 2022; 88(2):177-183. PubMed ID: 34491666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered Approach.
    Gowran RJ; Kennan A; Marshall S; Mulcahy I; Ní Mhaille S; Beasley S; Devlin M
    Patient; 2015 Feb; 8(1):51-63. PubMed ID: 25430517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis Bullosa in Spain: A Qualitative Analysis of Its Social Impact on Families With Diagnosed Minors.
    Martínez-Ripoll JM; García-Domingo M; de la Fuente Robles YM
    Health Expect; 2024 Aug; 27(4):e14128. PubMed ID: 38943541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychosocial impact of epidermolysis bullosa.
    Dures E; Morris M; Gleeson K; Rumsey N
    Qual Health Res; 2011 Jun; 21(6):771-82. PubMed ID: 21343430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.
    So JY; Fulchand S; Wong CY; Li S; Nazaroff J; Gorell ES; de Souza MP; Murrell DF; Teng JM; Chiou AS; Tang JY
    Orphanet J Rare Dis; 2022 Jul; 17(1):270. PubMed ID: 35841105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an epidermolysis bullosa family/parental burden score.
    Dufresne H; Hadj-Rabia S; Taieb C; Bodemer C
    Br J Dermatol; 2015 Dec; 173(6):1405-10. PubMed ID: 26281012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with epidermolysis bullosa.
    Tabolli S; Sampogna F; Di Pietro C; Paradisi A; Uras C; Zotti P; Castiglia D; Zambruno G; Abeni D
    Br J Dermatol; 2009 Oct; 161(4):869-77. PubMed ID: 19624546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
    Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
    JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa.
    Margari F; Lecce PA; Santamato W; Ventura P; Sportelli N; Annicchiarico G; Bonifazi E
    J Clin Psychol Med Settings; 2010 Dec; 17(4):333-9. PubMed ID: 21120591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.